Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,358 | 9,848 | 13,559 | 13,096 | 9,759 |
| Marketable Securities | 12,011 | 0 | N/A | N/A | 16,301 |
| Receivables | 2,535 | 1,246 | 1,542 | 1,335 | 487 |
| Inventories | 892 | 273 | 330 | 182 | 125 |
| Other current assets | 1,112 | 916 | 963 | 0 | 0 |
| TOTAL | $36,265 | $12,476 | $16,549 | $14,908 | $27,313 |
| Non-Current Assets | |||||
| PPE Net | 592 | 328 | 317 | 1,788 | 468 |
| Investments And Advances | 3,027 | 0 | 0 | 0 | 0 |
| Intangibles | 2,048 | 1,899 | 1,838 | 1,740 | 1,668 |
| Other Non-Current Assets | 31 | 440 | 439 | 1,475 | 768 |
| TOTAL | $5,698 | $2,666 | $2,594 | $5,004 | $2,904 |
| Total Assets | $41,963 | $15,141 | $19,143 | $19,911 | $30,217 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,139 | 1,773 | 1,882 | 2,104 | 805 |
| Accrued Expenses | 2,225 | 1,819 | 1,049 | 1,382 | 1,543 |
| TOTAL | $10,009 | $6,672 | $8,242 | $7,371 | $5,422 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,240 | 4,666 |
| Deferred Revenues | 5,644 | 3,080 | 5,312 | 1,180 | 965 |
| TOTAL | $810 | $1,843 | $2,051 | $5,298 | $7,295 |
| Total Liabilities | $10,819 | $8,515 | $10,293 | $12,668 | $12,717 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,696 | 87,573 | 82,361 | 68,050 | 65,530 |
| Common Shares | 1,036 | 842 | 818 | 681 | 655 |
| Retained earnings | -141,362 | -136,974 | -130,883 | -120,592 | -107,901 |
| Other shareholders' equity | -595 | -560 | -699 | -772 | -685 |
| TOTAL | $31,144 | $6,627 | $8,851 | $7,243 | $17,499 |
| Total Liabilities And Equity | $41,963 | $15,141 | $19,143 | $19,911 | $30,217 |